U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Red Rock Resorts, Kymera

U.S. stock index futures dipped on Monday following President Donald Trump's plans to double tariffs on imported steel and aluminum, fueling more uncertainty around U.S. trade policies. .N

Li Auto Inc :
BUZZ - Leads slide in EV makers, analysts cut TP on competition concerns nL2N3S505M

Cleveland Cliffs Inc :

Nucor Corp :

Steel Dynamics Inc :

Century Aluminum Co :
BUZZ - US steel companies capitalise on Trump's fresh tariff threat nL3N3S50I9

Moderna Inc :
BUZZ - Rises after US FDA nod for next-gen COVID-19 vaccine nL3N3S50IC

Blueprint Medicines Corp :
BUZZ - Gains on Sanofi's $9 bln buyout offer nL3N3S50J3

Life360 Inc :
BUZZ - Falls on planned $250 million convertible bond offering nL4N3RA1WB

Chevron Corp :

Exxon Mobil Corp :

Devon Energy Corp :

Diamondback Energy Inc :

BUZZ - Energy companies rise as OPEC+ keeps output increase unchanged nL3N3S50IX

Kura Oncology Inc :
BUZZ - Gains as FDA accepts marketing application for blood cancer drug nL3N3S50JX

Newmont Corp :

Barrick Gold Corp :

Gold Fields Ltd :

AngloGold Ashanti PLC :

BUZZ - Gold miners gain amid renewed trade and geopolitical tensions nL3N3S50J0

Xilio Therapeutics Inc :
BUZZ - Drops on equity raise plans nL6N3S50G9

Ford Motor Co :

General Motors Co :
BUZZ - Falls; President Trump increases tariff rate on imported steel nL3N3S50NO

Boeing Co :
BUZZ - Rises after BofA Global Research upgrades rating nL3N3S50NN

PotlatchDeltic Corp :

Rayonier Inc :

Weyerhaeuser Co :
BUZZ - Citigroup lowers PT on timber companies as lumber prices come under pressure nL3N3S50NW

Vera Therapeutics Inc :
BUZZ - Jumps after kidney disease drug succeeds in late-stage trial nL3N3S50OX

BioNTech SE :
BUZZ - Climbs on cancer drug deal with Bristol Myers nL3N3S50QM

Red Rock Resorts Inc :
BUZZ - Rises after Mizuho upgrades to 'outperform', hikes PT nL3N3S50QR

WPP PLC :
BUZZ - Drop after WSJ report on Meta's automated AI ad system nL5N3S50L3

Kymera Therapeutics Inc :
BUZZ - Rises after positive early-stage results for experimental drug nL3N3S50TX